Next-Gen Immunoengineering: A Cutting-Edge Approach That Prepares, Applies, and Manipulates the Immune System to Effectively Combat with the Diseases
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Cellular and Molecular Bioengineering".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 77
Special Issue Editor
Special Issue Information
Dear Colleagues,
Immunoengineering is a rapidly growing interdisciplinary field that integrates engineering tools and principles with immunology to harness the power of the immune system. It can potentially revolutionize the treatment of various diseases, including cancer, infectious diseases, diabetes, multiple sclerosis, and autoimmune diseases. By bringing together various fields such as biomedical engineering, immunology, medicine, biology, chemistry, material science, and chemical engineering, immunoengineering has the power to improve and enhance the overall quality of medical treatments. However, it still faces complex challenges that require a collaborative and multidisciplinary approach to unlock its full potential. The future of healthcare could be transformed by immunoengineering, but it will require the collective efforts of experts from different fields to make it happen. Do not settle for outdated methods—embrace the future of disease fighting with immunoengineering.
This research area comprises original research articles and reviews on immunotherapies for diagnosing, preventing, and treating immune system-related diseases. Potential subtopics include the following:
- Development of vaccines and immunotherapies;
- Engineering immune effector cell therapies;
- Immune cell manufacturing;
- Emergent rapid diagnostics and point-of-care technologies;
- Mechanobiology of immune cells and immune receptors;
- Application of systems immunology and computational and mathematical modeling to decipher host–immune interactions;
- Development of immunomodulatory biomaterials and therapies to manipulate the immune environment;
- Multiscale engineering of the immune system using materials, gene editing, synthetic biology, and immunodelivery tools;
- Development of single-cell analysis and multi-omics tools;
- Engineering multi-modal imaging tools and image-guided therapies.
Dr. Supriya Chakraborty
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunoengineering
- immunotherapy
- cell therapies
- immune cell manufacturing
